// COMPANY
LifeMine Therapeutics
SECTOR BIOTECHMENTIONS 3LAST SEEN AUGUST 27, 2026
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
funding·Parsers VC·AUGUST 27, 2026
“LifeMine Therapeutics raised $263M to leverage "fungal genomics" through its "Top-Down Drug Discovery platform" to find "novel precision medicines."”
02
product·Parsers VC·AUGUST 27, 2026
“LifeMine Therapeutics raised $263M to leverage "fungal genomics" through its "Top-Down Drug Discovery platform" to find "novel precision medicines."”
03
funding·Axios Pro Rata·AUGUST 6, 2026
“Raised $263m in combined Series D and E funding from backers like RA Capital Management, GV, GSK, Bill Gates, and Jeff Bezos.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.